Galen gets three year contract to chew on
Northern Ireland pharmaceutical company Galen Holdings said today it has won three-year exclusivity for its Ovcon product.
Ovcon is marketed in the US by Galen's subsidiary Warner Chilcott. The new product is in the form of chewable tablets.
CONNECT WITH US TODAY
Be the first to know the latest news and updates